Reviewed,
UniProtKB/Swiss-Prot O35245 (PKD2_MOUSE)
Last modified
June 16, 2009.
Version 81.
History...
Clusters with 100%,
90%,
50% identity |
Documents (2) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Polycystin-2 Alternative name(s): Polycystic kidney disease 2 protein homolog | ||
| Gene names |
| ||
| Organism | Mus musculus (Mouse) | ||
| Taxonomic identifier | 10090 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus |
Protein attributes
| Sequence length | 966 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at transcript level. |
General annotation (Comments)
| Function | Functions as a calcium permeable cation channel. PKD1 and PKD2 may function through a common signaling pathway that is necessary for normal tubulogenesis By similarity. |
| Subunit structure | Forms homooligomers. Interacts with PKD1. PKD1 requires the presence of PKD2 for stable expression. Interacts with CD2AP By similarity. |
| Subcellular location | Membrane; Multi-pass membrane protein Potential. |
| Tissue specificity | Expressed in mesenchymally derived structures in the developing embryo at day 12.5. In adult, mostly expressed in kidney. Ref.2 |
| Domain | The C-terminal coiled-coil domain binds calcium and undergoes a calcium-induced conformation change. It is implicated in oligomerization and the interaction with PKD1 By similarity. |
| Sequence similarities | Belongs to the polycystin family. Contains 1 EF-hand domain. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 966 | 966 | Polycystin-2 | PRO_0000164357 | |||||
Regions | |||||||||
| Topological domain | 1 – 221 | 221 | Cytoplasmic Potential | ||||||
| Transmembrane | 222 – 242 | 21 | Potential | ||||||
| Topological domain | 243 – 466 | 224 | Extracellular Potential | ||||||
| Transmembrane | 467 – 487 | 21 | Potential | ||||||
| Topological domain | 488 – 503 | 16 | Cytoplasmic Potential | ||||||
| Transmembrane | 504 – 524 | 21 | Potential | ||||||
| Topological domain | 525 – 548 | 24 | Extracellular Potential | ||||||
| Transmembrane | 549 – 569 | 21 | Potential | ||||||
| Topological domain | 570 – 596 | 27 | Cytoplasmic Potential | ||||||
| Transmembrane | 597 – 617 | 21 | Potential | ||||||
| Topological domain | 618 – 656 | 39 | Extracellular Potential | ||||||
| Transmembrane | 657 – 677 | 21 | Potential | ||||||
| Topological domain | 678 – 966 | 289 | Cytoplasmic Potential | ||||||
| Domain | 748 – 783 | 36 | EF-hand | ||||||
| Calcium binding | 761 – 772 | 12 | By similarity | ||||||
| Region | 702 – 792 | 91 | EF-hand domain By similarity | ||||||
| Region | 801 – 820 | 20 | Linker By similarity | ||||||
| Region | 821 – 966 | 146 | C-terminal coiled coil domain By similarity | ||||||
| Coiled coil | 837 – 917 | 81 | Potential | ||||||
| Motif | 314 – 326 | 13 | Polycystin motif | ||||||
| Compositional bias | 95 – 99 | 5 | Poly-Asp | ||||||
| Compositional bias | 151 – 154 | 4 | Poly-Arg | ||||||
Amino acid modifications | |||||||||
| Modified residue | 164 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 252 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 258 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 261 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 850 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 856 | 1 | Phosphoserine By similarity | ||||||
| Glycosylation | 297 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 303 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 326 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 360 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 373 | 1 | N-linked (GlcNAc...) Potential | ||||||
Experimental info | |||||||||
| Sequence conflict | 365 | 1 | I → M in CAA73727. Ref.2 | ||||||
| Sequence conflict | 365 | 1 | I → M in CAA74551. Ref.2 | ||||||
| Sequence conflict | 365 | 1 | I → M in CAA74552. Ref.2 | ||||||
| Sequence conflict | 370 | 1 | R → K in CAA73727. Ref.2 | ||||||
| Sequence conflict | 370 | 1 | R → K in CAA74551. Ref.2 | ||||||
| Sequence conflict | 370 | 1 | R → K in CAA74552. Ref.2 | ||||||
| Sequence conflict | 560 | 1 | A → S in CAA73727. Ref.2 | ||||||
| Sequence conflict | 560 | 1 | A → S in CAA74551. Ref.2 | ||||||
| Sequence conflict | 688 – 689 | 2 | DL → SV in CAA74551. Ref.2 | ||||||
| Sequence conflict | 746 | 1 | K → E in CAA73727. Ref.2 | ||||||
| Sequence conflict | 746 | 1 | K → E in CAA74551. Ref.2 | ||||||
| Sequence conflict | 942 | 1 | S → P in CAA73727. Ref.2 | ||||||
| Sequence conflict | 942 | 1 | S → P in CAA74551. Ref.2 | ||||||
| Sequence conflict | 957 | 1 | S → G in CAA73727. Ref.2 | ||||||
| Sequence conflict | 957 | 1 | S → G in CAA74551. Ref.2 | ||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Molecular cloning, cDNA sequence analysis, and chromosomal localization of mouse Pkd2." Wu G.Q., Mochizuki T., Le T.C., Cai Y., Hayashi T., Reynolds D.M., Somlo S. Genomics 45:220-223(1997) [PubMed: 9339380] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Characterization of the murine polycystic kidney disease (Pkd2) gene." Pennekamp P., Bogdanova N., Wilda M., Markoff A., Hameister H., Horst J., Dworniczak B. Mamm. Genome 9:749-752(1998) [PubMed: 9716661] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], TISSUE SPECIFICITY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| AF014010 mRNA. Translation: AAC53388.1. Y13278 mRNA. Translation: CAA73727.1. Y14105 Y14119 Genomic DNA. Translation: CAA74551.1. Y14120 mRNA. Translation: CAA74552.1. | |
| IPI | IPI00314352. |
| UniGene | Mm.476406 Mm.6442 |
3D structure databases | |
| HSSP | HSSP built from PDB template 1CB1 based on UniProtKB P02632. |
| ModBase | Search... |
PTM databases | |
| PhosphoSite | O35245. |
Proteomic databases | |
| PRIDE | O35245. |
Genome annotation databases | |
| Ensembl | ENSMUSG00000034462. Mus musculus. [Contig view] |
Organism-specific databases | |
| MGI | MGI:1099818. Pkd2. |
Phylogenomic databases | |
| HOGENOM | O35245. |
| HOVERGEN | O35245. |
Gene expression databases | |
| ArrayExpress | O35245. |
| Bgee | O35245. |
| CleanEx | MM_PKD2. |
| GermOnline | ENSMUSG00000034462. Mus musculus. |
Family and domain databases | |
| InterPro | IPR011992. EF-Hand_type. IPR018247. EF_HAND_1. IPR018249. EF_HAND_2. IPR013122. PKD1_2_channel. IPR003915. PKD_2. [Graphical view] |
| Gene3D | G3DSA:1.10.238.10. EF-Hand_type. 1 hit. |
| Pfam | PF08016. PKD_channel. 1 hit. [Graphical view] |
| PRINTS | PR01433. POLYCYSTIN2. |
| PROSITE | PS00018. EF_HAND_1. False negative. PS50222. EF_HAND_2. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| SOURCE | Search... |
Entry information
| Entry name | PKD2_MOUSE | ||||||||
| Accession | Primary (citable) accession number: O35245 Secondary accession number(s): Q9QWP0, Q9Z193, Q9Z194 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


